Atlas Trials

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077 in Type 2 Diabetic Subjects

Clinical trial NCT01551381 · TERMINATED

Trial details

NCT number
NCT01551381
Sponsor
Evolva SA
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2012-01-01
Primary completion
2012-05-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.